Aqueous extract of yerba mate tea lowers atherosclerotic risk factors in a rat hyperlipidemia model

Phytotherapy Research

Volumn 27, Issue 8, 2013, Pages 1225-1231

  Gao, Hongli ^a   Liu, Zhaochun ^b   Wan, Wenju ^a   Qu, Xiaolan ^a   Chen, Meihua ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

antioxidant activity; atherosclerosis; hyperlipidemia; serum lipid; Yerba Mate tea

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANTILIPEMIC AGENT; FATTY ACID SYNTHASE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WATER; YERBA MATE TEA EXTRACT;

ACC GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME BLOOD LEVEL; FAS GENE; GENE; GENE EXPRESSION REGULATION; HYPERLIPIDEMIA; ILEX PARAGUARIENSIS; LIPID STORAGE; LIVER CELL; LIVER FATTY DEGENERATION; LIVER INJURY; MALE; NONHUMAN; PLANT LEAF; PPARALPHA GENE; PROTEIN EXPRESSION; RAT; RISK FACTOR; SREBP 1C GENE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

CROTON OVALIFOLIUS; RATTUS;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; HYPERLIPIDEMIA; SERUM LIPID; YERBA MATE TEA;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; DISEASE MODELS, ANIMAL; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; ILEX PARAGUARIENSIS; LIVER; MALE; OXIDATIVE STRESS; PLANT EXTRACTS; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 84880720409     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4856     Document Type: Article

References (35)

1. Arçaria DP, Portob VB, Rodriguesa ERV, et al,. 2011. Effect of mate tea (Ilex paraguariensis) supplementation on oxidative stress biomarkers and LDL oxidisability in normo-and hyperlipidaemic humans. J Funct Foods 3: 190-197.
2. Bastos D, Saldanha L, Catharino R, et al,. 2007. Phenolic antioxidants identified by ESI-MS from yerba maté (Ilex paraguariensis) and green tea (Camellia sinensis) extracts. Molecules 12: 423-432.
3. Begriche K, Igoudjil A, Pessayre D, et al,. 2006. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6: 1-28.
4. Bixby M, Spieler L, Menini T, et al,. 2005. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci 77: 345-358.
5. Bracesco N, Sanchez AG, Contreras V, et al,. 2011. Recent advances on Ilex paraguariensis research: minireview. J Ethnopharmaco. 136: 378-384.
6. Burris KP, Davidson PM, Stewart CN Jr., et al,. 2011. Antimicrobial activity of Yerba Mate (ilex paraguariensis) aqueous extracts against Escherichia coli O157: h7 and Staphylococcus aureus. J Food Sci 76: 456-462.
7. Chiba M, Shinohara A, Matsushita K, et al,. 1996. Indices of lead-exposure in blood and urine of lead-exposed workers and concentrations of major and trace elements and activities of SOD, GSH-Px and catalase in their blood. Tohoku J Exp Med 178: 49-62.
8. Choi JS, Yokozawa T, Oura H,. 1991. Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin. Planta Med 57: 208-211.
9. Dembowski E, Davidson MH,. 2009. A review of lipid management in primary and secondary prevention. J Cardiopulm Rehabil Prev 29: 2-12.
10. De Morais EC, Stefanuto A, Klein GA,. 2009. Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy. J Agric Food Chem 57: 8316-24.
11. Durak I, Yurtarslanl Z, Canbolat O, et al., 1993. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 214: 103-104.
12. Gergerlioglu HS, Savas HA, Bulbul F, et al,. 2007. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog Neuropsychopharmacol Biol Psychiatry 31: 697-702.
13. Guven A, Guven A, Gulmez M,. 2003. The effect of kefir on the activities of GSHPx, GST, CAT, GSH and LPO levels in carbon tetrachloride-induced mice tissues. J Vet Med B Infect Dis Vet Public Health 50: 412-416.
14. Heck CI, de Mejia EG,. 2007. Yerba Mate Tea (Ilex paraguariensis), a comprehensive review on chemistry, healthimplications, and technological considerations J Food Sci 72: R138-R151.
15. Hou Y, Shao W, Xiao R, et al,. 2009. Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model. Exp Gerontol 44: 434-439.
16. Hsiai T, Berliner JA,. 2007. Oxidative stress as a regulator of murine atherosclerosis. Curr Drug Targets 8: 1222-1229.
17. Hussein GM, Matsuda H, Nakamura S, et al,. 2011. Protective and ameliorative effects of maté (Ilex paraguariensis) on metabolic syndrome in TSOD mice. Phytomedicine 19: 88-97.
18. Kim HY, Jeong DM, Jung HJ, et al,. 2008. Hypolipidemic effects of Sophora flavescens and its constituents in poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Biol Pharm Bull 31: 73-78.
19. Lei F, Zhang XN, Wang W, et al,. 2007. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. Int J Obes (Lond) 31: 1023-1029.
20. McBride P,. 2008. Triglycerides and risk for coronary artery disease. Current Atherosclerosis Report 10: 386-390.
21. 2-induced DNA damage and DNA repair in mice. Mutagenesis 23: 261-265.
22. Mosimann AL, Wilhelm-Filho D, Da Silva EL,. 2006. Aqueous extract of Ilex paraguariensis attenuates the progression of atherosclerosis in cholesterolifed rabbits. Biofactors 23: 1-12.
23. Ohlsen S,. 2004. Reducing hyperlipidaemia and CHD. Pharm J 273: 116-118.
24. Paganini Stein FL, Schmidt B, Furlong EB, et al,. 2005. Vascular responses to extractable fractions of Ilex paraguariensis in rats ed standard and high-cholesterol diets. Biol Res Nurs 7: 146-156.
25. Pang J, Choi Y, Park T,. 2008. Ilex paraguariensis extract ameliorates obesity induced by hyperlipidemic diet: potential role of AMPK in the visceral adipose tissue. Arch Biochem Biophys 476: 178-185.
26. Schinella G, Fantinelli JC, Tournier H, et al,. 2009. Antioxidant and cardioprotective effects of Ilex brasiliensis: a comparative study with Ilex paraguariensis (yerba mate). Food Res Int 42: 1403-1409.
27. Slater TF,. 1984. Overview of methods used for detecting lipid peroxidation. Methods Enzymol 105: 283-293.
28. Stein FLP, Schimidt B, Furlong EB,. 2005. Vascular responses to extractable fractions of Ilex paraguariensis in rats fed standard and high-chloesterol diets. Biol Res Nurs 7: 146-156.
29. Sun Y, Oberley LW, Li Y,. 1988. A simple method for clinical assay of superoxide dismutase. Clin Chem 34: 497-500.
30. Tapsell LC, Hemphill I, Cobiac L, et al,. 2006. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185 (Suppl 4): S4-S24.
31. Tarride JE, Lim M, DesMeules M, et al,. 2009. A review of the cost of cardiovascular disease. Can J Cardiol 25: 195-202.
32. Valko M, Leibfritz D, Moncol J, et al,. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44-84.
33. Zandbergen F, Plutzky J,. 2007. PPARα in atherosclerosis and inflammation. Biochim Biophys Acta 1771: 972-982.
34. Zaporozhets OA, Krushynska OA, Lipkovska NA, et al,. 2004. A new test method for the evaluation of total antioxidant activity of herbal products. J Agric Food Chem 52: 21-25.
35. Zhou Q, Liao JK,. 2009. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Design 15: 467-478.